Corporate News 14-May-19
Orchid Pharma receives ANDA approval for Risedronate Sodium Tablets
Orchid Pharma has received ANDA approval from USFDA for Risedronate Sodium Tablets USP, 30 mg and 35 mg.
Previous News
Orchid Pharma Ltd leads losers in 'B' group
( Hot Pursuit - 24-Jun-21 14:45 )
Orchid Pharma to conduct AGM
( Corporate News - 24-Jul-21 15:09 )
Orchid Pharma reports consolidated net loss of Rs 15.01 crore in the June 2022 quarter
( Results - Announcements 11-Aug-22 08:49 )
Orchid Chemicals gains over 13% in two sessions
( Hot Pursuit - 19-Mar-14 14:55 )
Orchid Pharma commissions expanded capacity of sterile plant at Alathur
( Corporate News - 01-Nov-23 14:57 )
Orchid Pharma consolidated net profit declines 44.27% in the March 2024 quarter
( Results - Announcements 24-May-24 07:34 )
Orchid Pharma to convene EGM
( Corporate News - 05-Dec-22 09:39 )
Orchid Pharma receives ratings action from CARE
( Corporate News - 30-Nov-23 18:51 )
Orchid Pharma reports consolidated net profit of Rs 9.40 crore in the June 2023 quarter
( Results - Announcements 12-Aug-23 12:13 )
Orchid Chemicals jumps 10.4% in two days
( Hot Pursuit - 03-Jan-12 13:19 )
Orchid Pharma reports consolidated net loss of Rs 44.72 crore in the December 2020 quarter
( Results - Announcements 10-Feb-21 08:08 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
